Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIFENOX: Enoxaparin in Acutely Ill Medical Patients
NCT00622648Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2008
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 4 trial of enoxaparin, sponsored by Sanofi. Started Jan 2008; status: completed.
02
Drugs
enoxaparin
Beyond the preview
Go deeper on NCT00622648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622648.